Elicio Therapeutics, Inc. Payments of Stock Issuance Costs
Elicio Therapeutics, Inc. (ELTX) reported Payments of Stock Issuance Costs of $500.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-13
- Elicio Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2026-06-30 was $500.00K.
- Elicio Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $100.00K.
- Elicio Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2024-06-30 was $2.40M, a 0.00% change year-over-year.
- Elicio Therapeutics, Inc. payments of stock issuance costs for the quarter ending 2023-06-30 was $2.40M, a 700.00% increase year-over-year.
- Elicio Therapeutics, Inc. payments of stock issuance costs for fiscal 2023 was $2.40M, a 100.00% increase from fiscal 2022.
- Elicio Therapeutics, Inc. payments of stock issuance costs for fiscal 2022 was $1.20M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2026-06-30 | $500.00K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $100.00K 10-Q · filed 2026-08-13 | ||
| 2024-06-30 | $2.40M 10-Q · filed 2024-08-13 | ||
| 2023-12-31 | $2.40M 10-K · filed 2024-03-29 | ||
| 2023-06-30 | $2.40M 10-Q · filed 2023-11-13 | ||
| 2022-12-31 | $1.20M 10-K · filed 2024-03-29 | ||
| 2022-09-30 | $700.00K 10-Q · filed 2023-11-13 | $1.00M derived: sum of 2 quarters · filed 2023-11-13 | |
| 2022-06-30 | $300.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |